bet356·体育在线(亚洲)最新官网入口-Flagship SPORTS

CN

TargetingOne Novel coronavirus testing qPCR series products were selected by the Ministry of Commerce as "White List" for export of epidemic prevention materials

release date:2021-11-30

In June 2020, novel Coronavirus(2019-nCov) Nucleic Acid Detection Kit(Digital PCR Method)
and the new coronavirus nucleic acid extraction reagent products jointly developed by TargetingOne and Tsinghua University were selected by the Ministry of Commerce as "White List" for export of epidemic prevention materials. After that, two other new coronavirus testing products independently developed by TargetingOne: SARS-COV-2 Nucleic Acid Detection Kits(Fluorescent PCR Method, SARS-COV-2 and Influenza A/B Nucleic Acid Detection Kits(Fluorescent PCR Method) were recently selected by Ministry of Commerce for the export of epidemic prevention materials "white list".

Attachment:

微信图片_20211130112535.jpg

SARS-COV-2 Nucleic Acid Detection Kits(Fluorescent PCR Method, SARS-COV-2 and Influenza A/B Nucleic Acid Detection Kits(Fluorescent PCR Method)

Reagents in lyophilized form: more stable composition, easier operation, more convenient transportation

High sensitivity: minimum detection value of 200 copies/mL

Applicable models: Applicable to a variety of qPCR models in domestic and foreign

Anti-contamination: closed operation throughout the whole process, reducing aerosol contamination

The arrival of winter and the prevalence of mutant strains of the new coronavirus have made the global situation of prevention and control of the new coronavirus epidemic severe. Screening and triage of suspected infected patients is important to quickly interrupt virus transmission and reduce public medical pressure.

These two products have been selected by the Ministry of Commerce as "White List" for export of epidemic prevention materials, further enriching the multi-technology platform testing solutions of TargetingOne, expanding and meeting the demand for testing and control at all levels in the global market, and contributing to the fight against the global epidemic. We will continue to contribute to the fight against global epidemics.